Table 1.
Baseline characteristics of study population
| Treatment Group* | ||||
|---|---|---|---|---|
| A n=42 |
B n=34 |
C n=34 |
D n=32 |
|
| Mean Age (y) | 40.9 | 39.1 | 43.1 | 44.4 |
| Gender (% male) | 45.2 | 47.1 | 44.1 | 40.6 |
|
Mean Baseline Serum Folate
(ng/mL) |
13.3 | 13.8 | 14.3 | 13.9 |
|
Mean Baseline RBC Folate
(ng/mL) |
515 | 562 | 520 | 517 |
| % 677TT Genotype | 14.3 | 23.5 | 17.6 | 9.4 |
| % African-American | 16.7 | 20.5 | 5.9 | 18.8 |
A=0 and 200 μg/day, B=200 and 0 μg/day, C=200 and 400 μg/day, D=400 and 200 μg/day